Pharmaceutical News

RSS

Drug shortages can be exacerbated by COVID-19 pandemic

A new paper published online in the Annals of the American Thoracic Society examines the nation's current shortage of vitally needed medications, and how this dangerous situation is being made worse by the COVID-19 pandemic.

11 Jun 2020

Researchers identify two brain phenomena that may explain the side-effects of ketamine

Researchers have identified two brain phenomena that may explain some of the side-effects of ketamine.

11 Jun 2020

Hydroxychloroquine suppresses 'trained immunity'

A new study published on the preprint server medRxiv in June 2020 shows that the drug hydroxychloroquine (HCQ) suppresses a form of immunity called ‘trained immunity,’ with repercussions for its potential use to treat COVID-19.

11 Jun 2020

Computational approach to design peptide-based vaccine against SARS-Cov-2

There are currently no licensed vaccines available for COVID-19. While several antiviral drugs have been tested, none has proved to be completely effective against the disease.

11 Jun 2020

Study: Better data on marijuana use is needed to support critical public health research

Better data on marijuana use in the U.S. is needed to support critical public health research, according to a review of relevant surveys conducted by University of Massachusetts Amherst researchers.

11 Jun 2020

GlobalData: Use of hydroxychloroquine as COVID19 treatment continues to be debated

There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.

10 Jun 2020

A drug to treat harsh complications of coronavirus infection is registered in Russia

Levilimab received state approval through a fast-track mechanism, according to Decree No. 441 of the Government of the Russian Federation of April 4, 2020, since its mechanism of action is associated with the control of the cytokine storm, which is one of the manifestations of coronavirus infection.

9 Jun 2020

Botox can be an effective treatment for certain sports injuries

While botulinum toxin is commonly known as a cosmetic treatment for facial lines and wrinkles, a growing body of evidence suggests that "Botox" can also be an effective treatment for certain sports injuries and chronic pain conditions, according to a review in the June issue of Current Sports Medicine Reports, official journal of the American College of Sports Medicine.

9 Jun 2020

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Santen Pharmaceutical Co., Ltd. and jCyte Inc. announced the conclusion of an exclusive licensing contract covering the development, registration and commercialisation rights in Japan, Asia and Europe to jCell, a first-in-class investigational therapy, currently in clinical development for retinitis pigmentosa.

From Santen Pharmaceutical Co., Ltd. 9 Jun 2020

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure.

9 Jun 2020

Scientists find way to prevent warmed-up vaccines from degrading

Vaccines are notoriously difficult to transport to remote or dangerous places, as they spoil when not refrigerated.

8 Jun 2020

New study highlights the credibility of registered clinical trials

In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) brings good news about the credibility of registered clinical trials.

5 Jun 2020

Study highlights increased consumption of opioids in patients with osteoarthritis

Fentanyl, tramadol or tilidine: New European figures show that even in Europe increasingly more people are taking opioids for pain connected with rheumatic and musculoskeletal diseases.

5 Jun 2020

New report documents trends before the legalization of cannabis in Michigan

Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.

5 Jun 2020

New platform can speed up the development of novel antibiotics

Harmful bacteria react less and less to common antibiotics. The infections they cause are therefore increasingly deadly.

4 Jun 2020

Health care providers urged to stop hydroxycholoroquine use for COVID-19

The sacred oath taken by physicians during graduation from medical school to "First do no harm," the first words of the Hippocratic Oath, provides a strong impetus for a commentary just published in The American Journal of Medicine.

4 Jun 2020

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Volume 11, Issue 22 of Oncotarget reported that despite relevant medical advancements, metastatic breast cancer remains an incurable disease.

3 Jun 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

First peer-reviewed publication on US trial results from Houston Methodist published in The American Journal of Pathology

3 Jun 2020

Study highlights the importance of child vaccine against infections

In the U.S., our children rarely fall ill to grave infections because they are protected by vaccines.

2 Jun 2020

Pharmaceutical News

Drug shortages can be exacerbated by COVID-19 pandemic

Researchers identify two brain phenomena that may explain the side-effects of ketamine

Hydroxychloroquine suppresses 'trained immunity'

Computational approach to design peptide-based vaccine against SARS-Cov-2

Study: Better data on marijuana use is needed to support critical public health research

GlobalData: Use of hydroxychloroquine as COVID19 treatment continues to be debated

A drug to treat harsh complications of coronavirus infection is registered in Russia

Botox can be an effective treatment for certain sports injuries

Santen Pharmaceutical and jCyte conclude an exclusive licensing contract in Japan, Asia and Europe for the jCell therapy programme for retinitis pigmentosa

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Scientists find way to prevent warmed-up vaccines from degrading

New study highlights the credibility of registered clinical trials

Study highlights increased consumption of opioids in patients with osteoarthritis

New report documents trends before the legalization of cannabis in Michigan

New platform can speed up the development of novel antibiotics

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

New drug can prevent life-threatening anaphylaxis, shows study

Convalescent plasma therapy improves outcomes in majority of COVID-19 patients

Study highlights the importance of child vaccine against infections

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News